Skip to main content

Table 3 Microvascular function (MVF), pulse amplitude, blood pressure, lung function (FEV 1 /FVC), and biomarkers of inflammation among 81 study participants

From: Vascular and lung function related to ultrafine and fine particles exposure assessed by personal and indoor monitoring: a cross-sectional study

Biomarkers

Total (n = 81)

Men (n = 41)

Women (n = 40)

MVF

1.9 (1.1, 3.1)

1.9 (1.1, 3.1)

1.9 (1.2, 3.4)

Log pulse amplitude

6.1 (4.3, 7.0)

6.4 (5.0, 7.0)

5.8 (4.2, 6.8)

Systolic blood pressure (mmHg)

120 (90, 150)

130 (110, 150)

120 (90, 140)

Diastolic blood pressure (mmHg)

70 (60, 90)

70 (60, 100)

70 (50, 85)

C-reactive protein (mg/L)

0.5 (0.1, 7.4)

0.5 (0.3, 7.5)

0.5 (0.1, 6.2)

Leukocytes (x109cells/L)

5.6 (3.3, 8.5)

5.2 (3.3, 8.5)

5.6 (3.5, 8.1)

Lymphocytes (x109cells/L)

1.7 (1.1, 2.6)

1.6 (1.0, 2.5)

1.7 (1.1, 3.2)

Monocytes (x109cells/L)

0.5 (0.2, 0.8)

0.5 (0.2, 0.7)

0.5 (0.2, 0.9)

Neutrophils (x109cells/L)

2.9 (1.6, 4.8)

2.8 (1.6, 5.6)

3.0 (1.7, 4.6)

Eosinophils (x109cells/L)

0.1 (0.0, 0.4)

0.1 (0.0, 0.4)

0.1 (0.0, 0.3)

FEV1/FVC

0.80 (0.7, 0.9)

0.80 (0.7, 0.9)

0.80 (0.7, 0.9)

  1. Values are medians (5th, 95th percentiles). MVF, Microvascular function; FEV1, Forced expiratory volume 1s (L); FVC, Forced vital capacity (L).